a Department of Diagnostic Imaging , Rhode Island Hospital , Providence , RI , USA.
b Department of Pathology , Rhode Island Hospital , Providence , RI , USA.
Int J Hyperthermia. 2018 Feb;34(1):11-18. doi: 10.1080/02656736.2017.1317367. Epub 2017 Apr 24.
To investigate the effects of a novel caesium-based thermal accelerant (TA) agent on ablation zone volumes following in vivo microwave ablation of porcine liver and skeletal muscle, and to correlate the effects of TA with target organ perfusion.
This prospective study was performed following institutional animal care and use committee approval. Microwave ablation was performed in liver and resting skeletal muscle in eight Sus scrofa domesticus swine following administration of TA at concentrations of 0 mg/mL (control), 100 mg/mL and 250 mg/mL. Treated tissues were explanted and stained with triphenyltetrazolium chloride (TTC) for quantification of ablation zone volumes, which were compared between TA and control conditions. Hematoxylin and eosin (H&E) staining was also performed for histologic analysis. General mixed modelling with a log-normal distribution was used for all quantitative comparisons (p = 0.05).
A total of 28 ablations were performed in the liver and 18 in the skeletal muscle. The use of TA significantly increased ablation zone volumes in a dose-dependent manner in both the porcine muscle and liver (p < 0.01). Both the absolute mean ablation zone volume and percentage increase in ablation zone volume were greater in the resting skeletal muscle than in the liver. In one swine, a qualitative mitigation of heat sink effects was observed by TTC and H&E staining. Non-lethal polymorphic ventricular tachycardia was identified in one swine, treated with intravenous amiodarone.
The use of a novel TA agent significantly increased mean ablation zone volumes following microwave ablation using a porcine model. The relationship between TA administration and ablation size was dose-dependent and inversely proportional to the degree of target organ perfusion, and a qualitative reduction in heat-sink effects was observed.
研究新型铯基热加速剂(TA)对猪活体微波消融后消融区域体积的影响,并将 TA 的影响与目标器官灌注相关联。
本前瞻性研究经机构动物护理和使用委员会批准后进行。在 TA 浓度为 0mg/mL(对照)、100mg/mL 和 250mg/mL 下,对 8 只家猪的肝脏和休息状态下的骨骼肌进行微波消融。处理后的组织用三苯基四唑氯化物(TTC)染色以定量消融区域体积,并在 TA 和对照条件之间进行比较。还进行了苏木精和伊红(H&E)染色以进行组织学分析。所有定量比较均采用具有对数正态分布的一般混合模型(p=0.05)。
共在肝脏进行了 28 次消融,在骨骼肌进行了 18 次消融。TA 的使用以剂量依赖的方式显著增加了猪肌肉和肝脏中的消融区域体积(p<0.01)。在休息状态下的骨骼肌中,绝对平均消融区域体积和消融区域体积的百分比增加均大于肝脏。在一只猪中,通过 TTC 和 H&E 染色观察到热沉效应的定性缓解。在一只接受静脉胺碘酮治疗的猪中,识别出非致死性多形性室性心动过速。
在猪模型中,使用新型 TA 剂显著增加了微波消融后的平均消融区域体积。TA 给药与消融大小之间的关系呈剂量依赖性,与目标器官灌注程度成反比,并且观察到热沉效应的定性降低。